CRISPR-Cas9
FDA Panel Approves First CRISPR Therapy After Rigorous Safety Evaluations
Anika Sharma
The FDA advisory committee has expressed satisfaction with the evaluation of potential off-target effects conducted by CRISPR Therapeutics and Vertex ...
CRISPR-Vertex’s gene editing therapy faces FDA committee review
Anika Sharma
A significant milestone in the pharmaceutical industry is on the horizon as an FDA advisory committee prepares to review the ...
